According to the research report, the global asthma treatment market size is expected to touch USD 30.1 Billion by 2027, from USD 26.7 Billion in 2022, growing with a significant CAGR of 2.6%.
The asthma treatment report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global asthma treatment in conjunction
with the geographical landscape of this vertical have also been included in
this report.
The report offers intricate dynamics about
different aspects of the global asthma treatment market, which aids companies
operating in the market in making strategic development decisions. The study
also elaborates on significant changes that are highly anticipated to configure
growth of the global asthma treatment during the forecast period. It also
includes a key indicator assessment that highlights growth prospects of this
market and estimates statistics related to growth of the market in terms of
value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/1557
This study covers a detailed segmentation
of the global asthma treatment market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global asthma treatment market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- AstraZeneca
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Roche Holding AG / Novartis AG
- Merck & Co., Inc.
- Koninklijke Philips N.V.
- Sanofi-Aventis SA
- MundiPharma.
Market Segmentation
- Quick-relief medication
- Long-term control medication
By Route of Administration
- Inhalers
- Prefilled syringes/vials
- Others
By Adjunct Therapy
- LAMA (long-acting muscarinic antagonists)
- LABA (long-acting beta antagonists)
- Others
By Distribution Channel
- Online pharmacies
- Hospital pharmacies
- Retail pharmacies & drug stores
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global asthma treatment report is based on detailed
primary as well as secondary research. With the help of in-depth insights of
the market-affiliated information that is obtained and legitimated by
market-admissible resources, analysts have offered riveting observations and authentic
forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global asthma treatment market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Asthma Treatment Market
5.1. COVID-19 Landscape: Asthma Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Asthma Treatment Market, By Medication
8.1. Asthma Treatment Market, by Medication Type, 2021-2027
8.1.1. Quick-relief medication
8.1.1.1. Market Revenue and Forecast (2019-2027)
8.1.2. Long-term control medication
8.1.2.1. Market Revenue and Forecast (2019-2027)
Chapter 9. Global Asthma Treatment Market, By Route of Administration
9.1. Asthma Treatment Market, by Route of Administration, 2021-2027
9.1.1. Inhalers
9.1.1.1. Market Revenue and Forecast (2019-2027)
9.1.2. Prefilled syringes/vials
9.1.2.1. Market Revenue and Forecast (2019-2027)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2019-2027)
Chapter 10. Global Asthma Treatment Market, By Adjunct Therapy
10.1. Asthma Treatment Market, by Adjunct Therapy, 2021-2027
10.1.1. LAMA (long-acting muscarinic antagonists)
10.1.1.1. Market Revenue and Forecast (2019-2027)
10.1.2. LABA (long-acting beta antagonists)
10.1.2.1. Market Revenue and Forecast (2019-2027)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2019-2027)
Chapter 11. Global Asthma Treatment Market, By Distribution Channel
11.1. Asthma Treatment Market, by Distribution Channel, 2021-2027
11.1.1. Online pharmacies
11.1.1.1. Market Revenue and Forecast (2019-2027)
11.1.2. Hospital pharmacies
11.1.2.1. Market Revenue and Forecast (2019-2027)
11.1.3. Retail pharmacies & drug stores
11.1.3.1. Market Revenue and Forecast (2019-2027)
Chapter 12. Global Asthma Treatment Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Medication (2019-2027)
12.1.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.1.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Medication (2019-2027)
12.1.5.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.1.5.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Medication (2019-2027)
12.1.6.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.1.6.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Medication (2019-2027)
12.2.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.2.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Medication (2019-2027)
12.2.5.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.2.5.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Medication (2019-2027)
12.2.6.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.2.6.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Medication (2019-2027)
12.2.7.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.2.7.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Medication (2019-2027)
12.2.8.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.2.8.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Medication (2019-2027)
12.3.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.3.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Medication (2019-2027)
12.3.5.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.3.5.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Medication (2019-2027)
12.3.6.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.3.6.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Medication (2019-2027)
12.3.7.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.3.7.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Medication (2019-2027)
12.3.8.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.3.8.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Medication (2019-2027)
12.4.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.4.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Medication (2019-2027)
12.4.5.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.4.5.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Medication (2019-2027)
12.4.6.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.4.6.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Medication (2019-2027)
12.4.7.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.4.7.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Medication (2019-2027)
12.4.8.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.4.8.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Medication (2019-2027)
12.5.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.5.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Medication (2019-2027)
12.5.5.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.5.5.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Medication (2019-2027)
12.5.6.2. Market Revenue and Forecast, by Route of Administration (2019-2027)
12.5.6.3. Market Revenue and Forecast, by Adjunct Therapy (2019-2027)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2027)
Chapter 13. Company Profiles
13.1. AstraZeneca
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Teva Pharmaceutical Industries Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. GlaxoSmithKline plc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Boehringer Ingelheim International GmbH
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Roche Holding AG / Novartis AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Merck & Co., Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Koninklijke Philips N.V.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Sanofi-Aventis SA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. MundiPharma
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments